Genetics
Metabolic Pathways and Multiple Sclerosis: What Mendelian Randomization Reveals31, Jul 2026
31, Jul 2026
30, Jul 2026
29, Jul 2026
Alper Bulbul
31, Jul 2026
This blog post examines a large metabolome-wide Mendelian randomization study that investigated whether circulating metabolites may contribute causally to multiple sclerosis risk. By integrating genetic data for hundreds of blood metabolites with a large multiple sclerosis genome-wide association study, the researchers prioritized 29 potential causal metabolites, including serine, lysine, acetone, acetoacetate, uridine, and lipids carried in specific lipoprotein subclasses. The findings illustrate the complex involvement of amino acid, energy, and lipid metabolism in multiple sclerosis while also emphasizing that genetically inferred lifelong effects should not be interpreted as direct clinical recommendations.
Read more30, Jul 2026
29, Jul 2026
